Form D · Venture Capital Fund

Pandect Bioventures, L.P.

South San Francisco, CA · CIK 0001757884

Offering snapshot reported Nov 23, 2020 · SEC filing

Reported sold: $33M
Investors reported: 2
Minimum accepted: $0
First sale: Nov 14, 2018

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 2

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 23, 2020	Amendment	$33,000,000	No comparison	2	SEC filing
Nov 13, 2018	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.1, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-325620

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Old City Securities LLC	171910	Old City Securities LLC · CRD 171910

Source: Form D, filed Nov 23, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

PANDECT BIOVENTURES, L.P.

Investment adviser: PANDECT BIOVENTURES MANAGEMENT, LLC

Gross asset value: $32.7M
Beneficial owners: 3
ADV minimum commitment: $3M

Reported in Form ADV on Apr 30, 2025. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator FIFE AVENUE PARTNERS DANVILLE, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG SAN FRANSISCO, California, United States

Marketer OLD CITY SECURITIES LLC NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: No
Administrator other than the adviser: Yes
External marketing: Yes

KPMG
PCAOB 185

OLD CITY SECURITIES LLC
CRD 171910 · SEC 8-69488

Filing source

Form ADV 1971406 · Apr 30, 2025 · Schedule D 7.B.(1), fund 805-8614743283

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Michael Hui	Director
Walter Moos	Director
N/A N/A Pandect Bioventures Gp, Llc	Director
Mohamad Tabrizi	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

280 Utah Avenue
South San Francisco, CA, 94080